JB Chem & Pharma
Ticker >

JB Chem & Pharma share price

JB Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM BSE: 506943 SECTOR: Pharmaceuticals & Drugs  79k   401   66

1779.55
-18.25 (-1.02%)
NSE: Today, 10:54 AM

Price Summary

Today's High

₹ 1795

Today's Low

₹ 1770.35

52 Week High

₹ 1940

52 Week Low

₹ 875

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 27617.69 Cr.

Enterprise Value

₹ 28088.86 Cr.

No. of Shares

15.52 Cr.

P/E

54.56

P/B

9.82

Face Value

₹ 1

Div. Yield

0.5 %

Book Value (TTM)

₹  181.14

CASH

₹ 55.76 Cr.

DEBT

₹ 526.93 Cr.

Promoter Holding

53.83 %

EPS (TTM)

₹  32.62

Sales Growth

31.7%

ROE

17.83 %

ROCE

22.02%

Profit Growth

7.72 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of JB Chemicals & Pharmaceuticals Ltd.

Doktor Mom Metrogyl Rantac Nicardia Molunamax

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year31.7%
3 Year20.69%
5 Year18.11%

Profit Growth

1 Year7.72%
3 Year13.19%
5 Year24.89%

ROE%

1 Year17.83%
3 Year21.36%
5 Year18.96%

ROCE %

1 Year22.02%
3 Year27.46%
5 Year24.73%

Debt/Equity

0.227

Price to Cash Flow

43.93

Interest Cover Ratio

16.3614005532028

CFO/PAT (5 Yr. Avg.)

0.956640112949624

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 53.83 0
Sep 2023 53.86 0
Jun 2023 53.91 0
Mar 2023 53.93 0
Dec 2022 53.95 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 20.6865471034312% for the Past 3 years.
  • Company has been maintaining healthy ROE of 21.3649800508337% over the past 3 years.
  • Company has been maintaining healthy ROCE of 27.4616852048768% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 16.3614005532028.
  • The Company has been maintaining an effective average operating margins of 23.1531074160708% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 34.9128272178162 days.
  • Company has a healthy liquidity position with current ratio of 2.53685123269586.
  • The company has a high promoter holding of 53.83%.

 Limitations

  • The company is trading at a high EV/EBITDA of 32.236.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 728.94 699.14 852.58 836.76 800.1
Total Expenditure 559.45 537.7 617.75 601.92 585.41
Operating Profit 169.49 161.44 234.83 234.84 214.69
Other Income 3.11 3.3 5.13 6.84 6.61
Interest 8.65 12.26 11.21 9.46 11.52
Depreciation 28.04 30.56 30.65 31.5 33.37
Exceptional Items 0 0 0 0 0
Profit Before Tax 135.91 121.92 198.1 200.72 176.41
Tax 34.7 33.25 53.53 55.7 48.49
Profit After Tax 101.21 88.67 144.57 145.02 127.92
Adjusted EPS (Rs) 6.54 5.73 9.34 9.36 8.25

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 1501.19 1640.74 1892 2189.88 2884.16
Total Expenditure 1212.75 1272.5 1339.66 1681.15 2219.47
Operating Profit 288.44 368.24 552.33 508.72 664.69
Other Income 40.23 49.57 115.92 38.8 8.65
Interest 4.57 3.16 7.19 4.95 34.31
Depreciation 54.82 65.09 67.36 71.28 111.99
Exceptional Items 0 -10 0 0 0
Profit Before Tax 269.28 339.56 593.71 471.29 527.04
Tax 87.22 71.42 146.62 110.29 138.15
Net Profit 182.06 268.14 447.08 361 388.89
Adjusted EPS (Rs.) 11.35 17.35 28.93 23.36 25.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 16.05 15.46 15.46 15.46 15.48
Total Reserves 1468.52 1429.83 1791 2088.21 2427
Borrowings 0 0 0 0 383.22
Other N/C liabilities 79.08 73.29 86.41 476.54 610.28
Current liabilities 763.27 493.55 645.74 418.54 579.28
Total Liabilities 2326.91 2012.13 2538.61 2998.75 4015.26
Assets
Net Block 552.11 583.21 564.6 1203.67 1821.66
Capital WIP 15.09 16.17 25.57 13.91 44.41
Intangible WIP 0 0 0 4.77 10.74
Investments 228.84 202.42 145.88 145.69 146.75
Loans & Advances 8.31 3.59 5.62 427.63 507.64
Other N/C Assets 0.59 0.36 0.82 1.04 14.51
Current Assets 1521.97 1206.39 1796.12 1202.05 1469.56
Total Assets 2326.91 2012.13 2538.61 2998.75 4015.26
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 269.28 339.56 593.71 471.29 527.04
Adjustment 26.87 15.19 -56.41 97.05 202.82
Changes in Assets & Liabilities -42.44 4.35 -61.45 -294.12 -12.62
Tax Paid -61.08 -87.15 -140.41 -127.12 -88.59
Operating Cash Flow 192.63 271.95 335.43 147.1 628.64
Investing Cash Flow -27.95 23.79 -230.64 4.18 -955.86
Financing Cash Flow -155.66 -305.48 -86.9 -137.85 343.41
Net Cash Flow 9.02 -9.75 17.9 13.42 16.2

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 53.95 53.93 53.91 53.86 53.83
tau investment holdings p... 53.95 53.93 53.91 53.86 53.83
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 46.05 46.07 46.09 46.14 46.17
axis mutual fund trustee ... - - 1.47 - 2.64
canara robeco mutual fund... - - - - 1.40
franklin india smaller co... 1.44 1.44 1.14 1.07 1.02
government pension fund g... 1.60 1.60 1.60 1.60 1.59
invesco india contra fund... - - - - 1.44
investor education and pr... 0.35 0.35 0.36 0.36 0.71
kotak mahindra life insur... 1.18 1.20 1.14 1.03 1.01
nippon life india trustee... - - - - 3.15
axis mutual fund trustee ... - 1.17 - 1.99 -
canara robeco mutual fund... 1.32 1.50 1.56 1.55 -
invesco india contra fund... 1.87 - 1.55 1.59 -
nippon life india trustee... 3.35 3.35 3.36 3.35 -
invesco india contra fund... - 1.91 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chem & Pharma - Quaterly Results6 Feb 2024, 4:00PM JB Chemicals & Pharmaceuticals to execute trade mark license agreement with Novartis Innovative Therapies AG19 Dec 2023, 2:43PM J.B. Chemicals & Pharmaceuticals informs about allotment of equity shares under ESOS30 Nov 2023, 10:30AM J.B. Chemicals & Pharmaceuticals informs about transcript of conference call13 Nov 2023, 5:18PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM JB Chem & Pharma - Quaterly Results7 Nov 2023, 3:29PM J.B.Chemicals & Pharmaceuticals informs about trading window closure27 Sep 2023, 5:23PM JB Chemicals & Pharmaceuticals gets USFDA’s nod for Doxepin Hydrochloride Capsules23 Aug 2023, 2:23PM JB Chemicals gets nod to set up wholly-owned step-down subsidiary in Philippines 9 Aug 2023, 5:20PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chem & Pharma - Quaterly Results9 Aug 2023, 3:43PM JB Chemicals & Pharmaceuticals informs about details of loss of certificate22 Jul 2023, 12:47PM USFDA completes inspection of J.B. Chemicals & Pharmaceuticals’ manufacturing facility at Gujarat12 Jun 2023, 2:50PM JB Chemicals & Pharmaceuticals reports 3% rise in Q4 consolidated net profit25 May 2023, 2:08PM J.B. Chemicals & Pharmaceuticals informs about disclosure of related party transactions25 May 2023, 9:41AM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results24 May 2023, 4:29PM JB Chem & Pharma - Quaterly Results8 Feb 2023, 6:31PM JB Chem & Pharma - Quaterly Results8 Feb 2023, 6:31PM J.B. Chemicals & Pharmaceuticals informs about disclosure23 Dec 2022, 11:13AM JB Chemicals & Pharmaceuticals acquires Razel franchise from Glenmark 22 Dec 2022, 10:43AM J. B. Chemicals & Pharmaceuticals informs about allotment of equity shares20 Dec 2022, 4:32PM JB Chemicals & Pharmaceuticals enters into agreement to acquire Razel franchise15 Dec 2022, 9:23AM J. B. Chemicals & Pharmaceuticals informs about closure of trading window 9 Dec 2022, 9:45AM JB Chemicals & Pharmaceuticals gets USFDA’s nod for Venlafaxine Extended Release Tablets30 Nov 2022, 4:12PM J.B. Chemicals & Pharmaceuticals informs about transcript of conference call 18 Nov 2022, 3:35PM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM JB Chem & Pharma - Quaterly Results12 Nov 2022, 10:15AM J.B.Chemicals & Pharmaceuticals informs about loss of share certificate28 Sep 2022, 1:32PM JB Chemicals & Pharmaceuticals informs about loss of share certificate9 Aug 2022, 4:04PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM JB Chem & Pharma - Quaterly Results4 Aug 2022, 7:05PM JB Chemicals acquires portfolio of brands from Dr Reddy’s22 Jul 2022, 11:06AM JB Chemicals gets nod to acquire four paediatric brands from Dr Reddy's Laboratories 30 Jun 2022, 12:26PM J.B. Chemicals & Pharmaceuticals informs about newspaper advertisement 3 Jun 2022, 2:36PM JB Chemicals & Pharmaceuticals informs about loss of share certificate3 Jun 2022, 2:32PM JB Chemicals & Pharmaceuticals’ arm to acquire 4.76% stake in Biotech Laboratories1 Jun 2022, 4:57PM JB Chem & Pharma - Quaterly Results26 May 2022, 3:33PM JB Chem & Pharma - Quaterly Results26 May 2022, 3:33PM JB Chem & Pharma - Quaterly Results26 May 2022, 3:33PM JB Chemicals acquires brand 'Azmarda' from Novartis13 Apr 2022, 10:34AM JB Chemicals & Pharmaceuticals reports 45% fall in Q3 consolidated net profit15 Feb 2022, 6:01PM JB Chem & Pharma - Quaterly Results14 Feb 2022, 6:23PM

JB Chem & Pharma Stock Price Analysis and Quick Research Report. Is JB Chem & Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into JB Chem & Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. JB Chem & Pharma cash from the operating activity was Rs 628.644 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. JB Chem & Pharma has a Debt to Equity ratio of 0.227 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In JB Chem & Pharma , the EPS growth was 7.59136244629359 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, JB Chem & Pharma has OPM of 23.0463342914503 % which is a good sign for profitability.
     
  • ROE: JB Chem & Pharma have a average ROE of 17.8311843094517 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of JB Chem & Pharma is Rs 1797.8. One can use valuation calculators of ticker to know if JB Chem & Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about JB Chem & Pharma

JB Chemicals & Pharmaceuticals Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 

 

Welcome to the stock analysis page for JB Chemicals & Pharmaceuticals Ltd, designed to provide in-depth analysis and insights for long-term stock investors. Explore various topics related to the company's performance and prospects to make informed investment decisions.

JB Chemicals & Pharmaceuticals Ltd Share Price 

Track and analyze the share price of JB Chemicals & Pharmaceuticals Ltd, a critical indicator for investors. Gain insights into the company's valuation and market sentiment using our pre-built screening tools.

JB Chemicals & Pharmaceuticals Ltd Balance Sheet 

Evaluate the financial stability and performance of JB Chemicals & Pharmaceuticals Ltd through its balance sheet analysis. Ticker offers valuable information, allowing you to understand the company's liquidity, solvency, and capital structure. Utilize our premium feature, BVPS Analysis, to calculate fair value based on the balance sheet.

JB Chemicals & Pharmaceuticals Ltd Annual Report 

Access the comprehensive annual report of JB Chemicals & Pharmaceuticals Ltd on Ticker. The annual report provides detailed information about the company's performance, strategic direction, and future plans. Download it from Ticker for a deeper understanding of the company's operations.

JB Chemicals & Pharmaceuticals Ltd Dividend 

Discover the dividend policy and track record of JB Chemicals & Pharmaceuticals Ltd, reflecting the company's commitment to rewarding shareholders. Our pre-built screening tools enable you to evaluate the company's dividend history and potential.

JB Chemicals & Pharmaceuticals Ltd Quarterly Results 

Stay updated on JB Chemicals & Pharmaceuticals Ltd quarterly performance through our detailed analysis. Our premium feature, Earnings Multiple Approach, helps assess the company's stock value based on its quarterly results.

JB Chemicals & Pharmaceuticals Ltd Stock Price 

Monitor the stock price of JB Chemicals & Pharmaceuticals Ltd to understand market sentiment and price movement. Our platform provides a comprehensive stock price chart for assessing historical performance and trends.

JB Chemicals & Pharmaceuticals Ltd Price Chart 

The price chart visually represents the historical performance of JB Chemicals & Pharmaceuticals Ltd stock. Analyze patterns, trends, and price levels to make well-informed investment decisions.

JB Chemicals & Pharmaceuticals Ltd News 

Stay up to date with the latest news articles about JB Chemicals & Pharmaceuticals Ltd through our dedicated news section. Timely information is crucial for investors, and Ticker ensures you are informed about the company's developments.

JB Chemicals & Pharmaceuticals Ltd Concall Transcripts 

Gain deeper insights into JB Chemicals & Pharmaceuticals Ltd's operations and plans by accessing transcripts of conference calls with analysts and investors. These transcripts provide valuable information about the company's strategies and future outlook.

JB Chemicals & Pharmaceuticals Ltd Investor Presentations 

View informative investor presentations of JB Chemicals & Pharmaceuticals Ltd, providing insights into the company's growth prospects and investment opportunities. Ticker offers access to these presentations, helping you understand the company's value proposition.

JB Chemicals & Pharmaceuticals Ltd Promoters & Shareholders 

Understand the ownership structure of JB Chemicals & Pharmaceuticals Ltd by learning about the key promoters and major shareholders. This information can help gauge ownership concentration and potential alignment of interests.

Read More
X